Abzu scales discoveries in pharma R&D.
We accelerate exploration, understanding, and insights in pharma R&D with our expertise in pharma, AI, bioinformatics, and data science.
Support your team, project, and pipeline.
Abzu uses scientific expertise and new technologies to accelerate pharma R&D.
Abzu's pharma R&D services include:
Unlock new disease mechanisms and discover novel biomarkers.
Design better drugs by understanding the mechanisms behind drug properties and activity.
Engage with biotech’s and pharma’s premier external data science experts.
Every pharma R&D team, project, and pipeline is unique.
And we want to hear about yours.
Contact Abzu pharma.
How can Abzu accelerate your exploration and understanding?
Abzu’s proprietary discovery engine: The QLattice®.
Our QLattice® discovery engine is a new class of artificial intelligence (AI), built in-house on our patented technology.
Models developed by the QLattice have unparalleled accuracy, even with very little data, and are uniquely simple to understand.
Abzu R&D accelerates scientific discoveries.
Abzu's technology is cited in industry-leading publications and reports.
Predicting weight loss success on a new Nordic diet: an untargeted multi-platform metabolomics and machine learning approach.
A novel QLattice-based whitening machine learning model of landslide susceptibility mapping.
Plasma proteomics discovery of mental health risk biomarkers in adolescents.
Analysis of the relationship between fetal health prediction features with machine learning Feyn QLattice regression model.